Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  asparaginase Erwinia chrysanthemi
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-6 of 6 for your search:
Start Over
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 1 to 31
Sponsor: NCI
Protocol IDs: NCI-2011-01908, CDR0000638413, AALL07P1, U10CA180886, U10CA098543, COG-AALL07P1, NCT00873093
A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Completed
Age: 1 to 30
Sponsor: Pharmaceutical / Industry
Protocol IDs: 100EUSA12, NCT01643408
Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma
Phase: Phase I
Type: Treatment
Status: Completed
Age: 0-21
Sponsor: Other
Protocol IDs: ERWASE, NCT00693602
Erwinase Study in Patients With Acute Lymphoblastic Leukemia
Phase: No phase specified
Type: Treatment
Status: Completed
Age: Any age
Sponsor: Other
Protocol IDs: 2007-0183, NCT00506597
Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 1 to 30
Sponsor: NCI, Other
Protocol IDs: AALL07P2, NCI-2009-00316, COG-AALL07P2, CDR0000566349, U10CA098543, NCT00537030
Start Over